Journal of Clinical and Molecular Endocrinology

Keywords

Type 2 diabetes, Paediatrics, Diabetes, Obesity, Metabolic syndrome, Beta-cell failure

Introduction

Type 2 diabetes mellitus is developing as a new clinical problem within pediatric practice. Recent reports show an increasing prevalence of type 2 diabetes mellitus in children and teenagers around the world in all ethnicities, even if the prevalence of corpulence isn't increasing any more. Hence, a screening seems meaningful especially in high risk groups such as children and teenagers with corpulence, relatives with type 2 diabetes mellitus, and clinical features of insulin resistance (hypertension, dyslipidemia, polycystic ovarian disorder, or acanthosis nigricans) [1]. Treatment of choice is way of life mediation followed by pharmacological treatment (e.g., metformin). New drugs such as dipeptidyl peptidase inhibitors or glucagon like peptide 1 mimetics are in the pipeline for treatment of youth with type 2 diabetes mellitus [2]. In any case, recent reports show a high dropout of the restorative care framework of teenagers with type 2 diabetes mellitus suggesting that management of children and teenagers with type 2 diabetes mellitus requires some rebuilding of current healthcare practices [3].

Pathophysiology of Paediatric Type 2 Diabetes

The pathophysiology of T2DM starts with declines in skeletal muscle, adipose tissue, and hepatic insulin sensitivity, which necessitates increased pancreatic beta-cell insulin secretion to maintain glucose homeostasis [4]. Hyperglycemia develops when compensatory insulin secretion fails to counter worsening insulin sensitivity and manifests as prediabetes and, ultimately, T2DM. Hyperglycemic clamp testing has shown that, compared with obese controls without T2DM, youth who develop pediatric T2DM have 50% reduced insulin sensitivity, increased fasting hepatic glucose production, and an 86% lower disposition index (a composite measure describing the relationship between insulin sensitivity and beta-cell function) [5]. In addition, insulin secretion can be sufficiently deficient to precipitate diabetes ketoacidosis (DKA), which occurs in w6% of cases of pediatric T2DM but is an uncommon presentation in adult T2DM. Similar to adult T2DM, pediatric T2DM can present with hyperosmolar hyperglycemic nonketoacidosis (HHNK), a condition that should be considered if blood glucose level is greater than or equal to 600 mg/Dl [6].

Obesity is a primary risk factor for reduced insulin sensitivity in children and adults. The metabolic syndrome comprises the clustering of disorders related to central obesity, including insulin resistance, hypertension, and dyslipidemia [7]. Other risk factors in adults and children include conditions associated with insulin resistance (such as polycystic ovary syndrome [PCOS]), firstdegree relative with T2DM, and high-risk racial minority groups. A first-degree or second-degree relative with T2DM is present in 74% to 100% of youth with T2DM [8]. Moreover, Magge and colleagues showed that siblings of adolescents with T2DM had 4-times greater odds of abnormal glucose tolerance compared with overweight controls. Several adult T2DM-related genetic variants, such as the TCF7L2 locus, have also been identified in African American youth with T2DM and HNF1A G319S in Oji-Cree Native Canadian youth [9].

For youth with genetic or other risk factors, obesity and the onset of puberty can precipitate the development of T2DM. Puberty in adolescents leads to an approximately 30% reduction in insulin sensitivity, and most new pediatric T2DM diagnoses occur during puberty [10]. Among perinatal risk factors, infants born to mothers with gestational diabetes and children born small-for-gestational-age are at a higher risk for development of metabolic syndrome, insulin resistance, and T2DM in childhood.

Epidemiology of Paediatric Type 2 Diabetes

The prevalence of type 2 diabetes mellitus in youngsters and teenagers in the United States is roughly 12:100000, while it is as yet uncommon in Europe (around 2.5:100000) [11]. Most of youngsters determined to have type 2 diabetes mellitus was found in explicit ethnic subgroups, for example, African- American, Hispanic, Asian/Pacific Islanders and American Indians being most noteworthy in Pima Indians (22.3/1000 of every 10 - 14-year-old kids) [12]. Besides, the incredible larger part of the adolescents was hefty. Screening concentrates in stout youths have revealed a predominance of 0.4% up to 1% of type 2 diabetes mellitus in hefty adolescent’s ≥ 12 years. Inside the entire pediatric partner studied, the general frequency of type 2 diabetes mellitus stayed low when contrasted and type 1 diabetes mellitus. This had driven a few analysts to scrutinize the cases of a "pestilence" of pediatric kind 2 diabetes mellitus; although there is general agreement that type 2 diabetes mellitus in youth appears to be emerging as a serious clinical issue [13].

Diagnostic Criteria of Paediatric Type 2 Diabetes

The measures for finding of diabetes mellitus in youngsters and youths are indications of diabetes mellitus, for example, polydipsia, polyuria, and unexplained weight reduction in addition to easygoing glucose focus ≥ 200 mg/dL (11.1 mmol/L) in venous plasma, fasting glucose ≥ 126 mg/dL (7.0 mmol/L) in venous or narrow plasma, or two-hours glucose during oGTT ≥ 200 mg/dL (11.1 mmol/L) in venous plasma or fine entire blood test. As of late amended American Diabetes mellitus Association (ADA) standards permit usage of hemoglobin A1c (HbA1c) ≥ 6.5% for determination of diabetes mellitus. If there should arise an occurrence of asymptomatic appearance, fasting glucose, HbA1c, or oGTT test must be rehashed on one more day for finding [14].

In many patients with diabetes mellitus, characterization can be made dependably based on clinical introduction and course. In the irregular situation that requires a particular grouping to be made, other test might be important, for example, fasting insulin or C-peptide assurance and infrequently, β-cell autoantibodies estimations [15]. To accomplish a serious level of affectability, a mix of test is required, which extraordinarily builds the expense of arrangement. C-peptide levels are raised in people with type 2 diabetes mellitus rather than patients with type 1 diabetes mellitus or MODY diabetes [16]. Explicit autoantibodies to insulin, to GAD-ii, or to tyrosine phosphatases insulin antibodies (IA) - 2 and IA-2b are found at introduction in 85%-98% of people with immune mediated type 1 diabetes mellitus. Type 1 diabetes mellitus additionally has a solid HLA affiliation; in any case, HLA composing is certainly not a valuable symptomatic instrument [17].

Complications of Paediatric Type 2 Diabetes

The constant difficulties of diabetes mellitus in grown-ups incorporate full scale vascular illness like quickened advancement of cardiovascular sickness prompting stroke and myocardial localized necrosis, and miniature vascular infections like retinopathy, nephropathy and neuropathy prompting end-stage renal sickness, loss of visual sharpness, and appendage removals. These confusions add to the abundance dismalness and mortality in people with diabetes mellitus [18]. One remarkable result of the UK Prospective Diabetes mellitus Study (UKPDS) investigation was the perception that the accumulation of endpoints was a period subordinate cycle. Subsequently, kids and young people with type 2 diabetes mellitus have a higher danger for difficulty when contrasted with grown-ups with diabetes mellitus. Likewise, creating type 2 diabetes mellitus at a more youthful age is additionally connected with a lot higher danger of long haul cardiovascular illness than the individuals who create type 2 diabetes mellitus in middle age. Adolescents with type 2 diabetes mellitus seem, by all accounts, to be at a lot higher danger of growing early diabetes mellitus [19]. Related intricacies than those with type 1 diabetes mellitus. This more significant level of danger doesn't have all the earmarks of being identified with generally speaking degrees of glycaemic control or length of sickness however to event of hypertension and dyslipidaemia. These cardiovascular danger factors are more successive in young people experiencing type 2 diabetes mellitus contrasted with type 1 diabetes mellitus. In the TODAY study, 14% of teenagers with type 2 diabetes mellitus experienced hypertension, 80% showed low HDL fixations, and 10% had hypertriglyceridemia. In the SEARCH study, 92% of the youths with type 2 diabetes mellitus satisfied the meaning of metabolic disorder. This current commonness' are like cardiovascular danger factors in European teenagers with type 2 diabetes mellitus [20].

We know little about the beginning and progress of macro vascular sickness in youngsters and teenagers with type 2 diabetes mellitus. Arteriosclerosis is a period subordinate marvel, and in this manner the total time from finding to creating neurotic cardiovascular injuries might be numerous years - in that sense these youngsters might be ensured by age since they don't have previous age related cardiovascular illness. In any case, as of now teenagers with type 2 diabetes mellitus exhibited an expanded intima-media thickness, which is prescient for coronary episode and stroke. Micro vascular infection is the sign of hyperglycaemia analysed at a youthful age [21]. Information from Japanese, Pima Indian kids shows the presence of micro vascular diabetic difficulties as of now at analysis and follow-up. In Japanese youngsters, nascent retinopathy was identified in 36% of the cases at the hour of analysis, and in 39% of the cases at 2 years follow-up, while micro albuminuria was seen in 39% at 2 years follow-up. Among Pima Indian youngsters, 22% had micro albuminuria, and at follow-up somewhere in the range of 20 and 29 years old 60% had micro albuminuria and 17% had as of now macro albuminuria. In the SEARCH study, 4% of the young people with type 2 diabetes mellitus exhibited retinopathia and 28% micro albuminuria. Conversely, in European young people with type 2 diabetes mellitus no retinopathia and just 5% micro albuminuria was accounted for proposing hereditary contrasts [22].

Monitoring and Treatment of Complications of Paediatric Type 2 Diabetes

Since microvascular inconveniences of type 2 diabetes mellitus like retinopathy and nephropathy as of now happen in kids, expanded eye assessments ought to be performed. Screening for microalbuminuria ought to likewise be performed yearly [23]. Angiotensin changing over chemical (ACE) inhibitors are the specialists of decision in kids with microalbuminuria. It is hazy whether foot assessments are significant in kids [24]. Control of hypertension in youngsters with type 2 diabetes mellitus is required. In the event that normotension isn't accomplished by ACE inhibitors, mix treatment with a-blockers, calcium rivals or low-portion diuretics might be required. Testing for and treating lipid irregularities are important to stay away from macrovascular illnesses [25].

Conclusion

Type 2 diabetes mellitus is as yet uncommon in adolescence and, however late reports show an expanding commonness around the globe potentially because of expanding pervasiveness of heftiness in kids and teenagers. This is especially the situation in the United States however has likewise been accounted for in different nations in Asian and Europe. It is turning out to be progressively certain that large kids and young people with clinical indications of insulin opposition (acanthosis nigricans, dyslipidemia, hypertension, PCOS) or family members with type 2 diabetes mellitus or of specific ethnic populaces (Asian, American Indian, AfricaAmericans, Hispanics) over the age of 10 years ought to be screened for type 2 diabetes mellitus. Avoidance and treatment of type 2 diabetes mellitus should get one of the practical objectives of general wellbeing mediation programs. Considerably more consideration ought to be given to the counteraction and improvement of preventive systems right off the bat throughout everyday life. At last, and above all, public consciousness of the expanding wellbeing trouble and financial element of the youth weight pestilence is of significance. Doctors should make the public aware of both the youth corpulence scourge and its genuine results; not least type 2 diabetes mellitus.

References

1. Arslanian S. Type 2 diabetes in children: clinical aspects and risk factors. Hormone Research in Paediatrics. 2002;57(Suppl. 1):19-28.
2. Rodriguez BL, Fujimoto WY, Mayer-Davis EJ, Imperatore G, Williams DE, Bell RA, Wadwa RP, Palla SL, Liu LL, Kershnar A, Daniels SR. Prevalence of cardiovascular disease risk factors in US children and adolescents with diabetes: the SEARCH for diabetes in youth study. Diabetes care. 2006 Aug 1;29(8):1891-6.
3. Reinehr T. Clinical presentation of type 2 diabetes mellitus in children and adolescents. International Journal of Obesity. 2005 Sep;29(2):S105-10.
4. Awa WL, Boehm BO, Rosinger S, Achenbach P, Ziegler AG, Krause S, Meissner T, Wiegand S, Reinehr T, Kapellen T, Karges B. HLA‐typing, clinical, and immunological characterization of youth with type 2 diabetes mellitus phenotype from the German/Austrian DPV database. Pediatric diabetes. 2013 Dec;14(8):562-74.
5. Schober E, Waldhoer T, Rami B, Hofer S, Austrian Diabetes Incidence Study Group. Incidence and time trend of type 1 and type 2 diabetes in Austrian children 1999–2007. The Journal of pediatrics. 2009 Aug 1;155(2):190-3.
6. Drake AJ, Smith A, Betts PR, Crowne EC, Shield JP. Type 2 diabetes in obese white children. Archives of disease in childhood. 2002 Mar 1;86(3):207-8.
7. American Diabetes Association. Type 2 diabetes in children and adolescents. Pediatrics. 2000 Mar 1;105(3):671-80.
8. Schober E, Holl RW, Grabert M, Thon A, Rami B, Kapellen T, Seewi O, Reinehr T. Diabetes mellitus type 2 in childhood and adolescence in Germany and parts of Austria. European journal of pediatrics. 2005 Nov 1;164(11):705-7.
9. Springer SC, Silverstein J, Copeland K, Moore KR, Prazar GE, Raymer T, Shiffman RN, Thaker VV, Anderson M, Spann SJ, Flinn SK. Management of type 2 diabetes mellitus in children and adolescents. Pediatrics. 2013 Feb 1;131(2):e648-64.
10. Rosenbloom AL, Silverstein JH, Amemiya S, Zeitler P, Klingensmith GJ. Type 2 diabetes mellitus in the child and adolescent. Pediatric diabetes. 2008 Oct;9(5):512-26.
11. Arslanian SA. Type 2 Diabetes Mellitus in Children: Pathophysiology and Risk Factors: Division of Pediatric Endocrinology, Metabolism and Diabetes Mellitus Children’s Hospital of Pittsburgh, Pennsylvania, USA. Journal of Pediatric endocrinology and Metabolism. 2000 Dec 1;13(Supplement):1385-94.
12. Lobstein T, Frelut ML. Prevalence of overweight among children in Europe. Obesity reviews. 2003 Nov;4(4):195-200.
13. Han JC. Law lor DA, Kimm SY Chil d ho od obe si ty. The Lan cet. 2010 May 15;375(9727):1737-48.
14. Moss A, Klenk J, Simon K, Thaiss H, Reinehr T, Wabitsch M. Declining prevalence rates for overweight and obesity in German children starting school. European journal of pediatrics. 2012 Feb 1;171(2):289-99.
15. May AL, Kuklina EV, Yoon PW. Prevalence of cardiovascular disease risk factors among US adolescents, 1999− 2008. Pediatrics. 2012 Jun 1;129(6):1035-41.
16. Kiess W, Böttner A, Raile K, Kapellen T, Müller G, Galler A, Paschke R, Wabitsch M. Type 2 diabetes mellitus in children and adolescents: a review from a European perspective. Hormone Research in Paediatrics. 2003;59(Suppl. 1):77-84.
17. Florez JC. The genetics of type 2 diabetes: a realistic appraisal in 2008. The Journal of Clinical Endocrinology & Metabolism. 2008 Dec 1;93(12):4633-42.
18. Abokaf H, Shoham-Vardi I, Sergienko R, Landau D, Sheiner E. In utero exposure to gestational diabetes mellitus and long term endocrine morbidity of the offspring. Diabetes Research and Clinical Practice. 2018 Oct 1;144:231-5.
19. Abokaf H, Shoham-Vardi I, Sergienko R, Landau D, Sheiner E. In utero exposure to gestational diabetes mellitus and long term endocrine morbidity of the offspring. Diabetes Research and Clinical Practice. 2018 Oct 1;144:231-5.
20. Kleber M, Desousa G, Papcke S, Wabitsch M, Reinehr T. Impaired glucose tolerance in obese white children and adolescents: three to five year follow-up in untreated patients. Experimental and clinical endocrinology & diabetes. 2011 Mar;119(03):172-6.
21. Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, Yeckel CW, Allen K, Lopes M, Savoye M, Morrison J, Sherwin RS. Obesity and the metabolic syndrome in children and adolescents. New England journal of medicine. 2004 Jun 3;350(23):2362-74.
22. Taksali SE, Caprio S, Dziura J, Dufour S, Calí AM, Goodman TR, Papademetris X, Burgert TS, Pierpont BM, Savoye M, Shaw M. High visceral and low abdominal subcutaneous fat stores in the obese adolescent: a determinant of an adverse metabolic phenotype. Diabetes. 2008 Feb 1;57(2):367-71.
23. Wabitsch M, Hauner H, Hertrampf M, Muche R, Hay B, Mayer H, Kratzer W, Debatin KM, Heinze E. Type II diabetes mellitus and impaired glucose regulation in Caucasian children and adolescents with obesity living in Germany. International journal of obesity. 2004 Feb;28(2):307-13.
24. Copeland KC, Zeitler P, Geffner M, Guandalini C, Higgins J, Hirst K, Kaufman FR, Linder B, Marcovina S, McGuigan P, Pyle L. Characteristics of adolescents and youth with recent-onset type 2 diabetes: the TODAY cohort at baseline. The Journal of Clinical Endocrinology & Metabolism. 2011 Jan 1;96(1):159-67.
25. Wilkin TJ. The accelerator hypothesis: a unifying explanation for type-1 and type-2 diabetes. InNutritional Management of Diabetes Mellitus and Dysmetabolic Syndrome 2006 (Vol. 11, pp. 139-153). Karger Publishers.